DSL(603233) 证券日报·2025-04-26 00:07Core Viewpoint - The company has reported its first-quarter financial data for 2025, highlighting a strategic focus on expanding its retail business while managing store closures and optimizing its operations [29][30]. Financial Data - The company has not conducted an audit for the first-quarter financial report [3]. - The total number of stores as of March 31, 2025, is 16,622, with a total operating area of 896,747 square meters [30]. - The company closed 174 stores during the reporting period, primarily due to local planning and strategic adjustments [32]. Business Performance - Retail business accounts for 83.26% of the company's operations, with a focus on expanding in the South China region while also penetrating other regions [30]. - The fastest-growing product category in the first quarter of 2025 was traditional Chinese and Western medicine, with a growth rate of 5.80% [30]. - The company experienced a decline in retail revenue due to the closure of stores and the high revenue from the previous year caused by a flu outbreak [30]. Regional Development - The company has achieved a revenue growth rate of 10.70% in Northeast, North China, Northwest, and Southwest regions, driven by store acquisitions [31]. - The company continues to implement its strategy of expanding outside its established regions, maintaining balanced growth across various areas [31]. Related Transactions - The company has reported that its related transactions for 2024 amounted to 171.16 million yuan, which is within the expected limit of 220.70 million yuan [10]. - For 2025, the company anticipates providing guarantees for subsidiaries to apply for a total of up to 7.765 billion yuan in comprehensive financing [11][25].